The nature of the beast is yes, these drugs come off patent; the demand is there and someone could produce it more cheaply’, ...

Online master’s degrees in engineering and education from Purdue again rank among the nation’s finest. Four of Pur ...

Neurocrine Biosciences, Inc. today announced that Andrew Ratz, Ph.D., has joined the company as Senior Vice President of Drug Development, Delivery and Device. In this role, Dr. Ratz will lead the ...

Eli Lilly has said it is seeking permission to build ... €400 million ($445 million), and could create 300 jobs at the plant itself, with another 500 positions required while it is under ...

MILWAUKEE — Microsoft bought 240 acres of land from Kenosha with goals for future data center development.

K-Bio leaders pursue U.S. factories and conferences during Lunar New Year K-Bio executives opt for international business ...

Tracey Allen Franks, age 59, of Indianapolis, IN, was born on Nov. 26, 1965, in Seymour, IN, to parents Bruce and Virginia ...

Microsoft boguht 240 acres in Kenosha, Wis. for future data center development, a boost for local innovation and economic ...

Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...

Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has another enormous opportunity that's getting very little attention.

If Eli Lilly has its way, this may be the future of obesity care. Eli Lilly makes some of the most powerful weight-loss drugs in the world. The company has pivoted dramatically over the past ...

Eli Lilly is experiencing explosive growth thanks to its diabetes and obesity treatments. Beyond weight loss, the company is quietly building a fast-growing oncology business. This is an enormous ...